Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M407329200 on September 28, 2004

J. Biol. Chem., Vol. 279, Issue 49, 50949-50955, December 3, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/49/50949    most recent
M407329200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vidali, M.
Right arrow Articles by Ingelman-Sundberg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vidali, M.
Right arrow Articles by Ingelman-Sundberg, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Use of Molecular Simulation for Mapping Conformational CYP2E1 Epitopes*

Matteo Vidali{ddagger}, Mats Hidestrand§, Erik Eliasson¶, Elisa Mottaran{ddagger}, Emanuela Reale{ddagger}, Roberta Rolla{ddagger}, Giuseppa Occhino{ddagger}, Emanuele Albano{ddagger}||, and Magnus Ingelman-Sundberg§

From the {ddagger}Department of Medical Science, University "Amedeo Avogadro" of East Piedmont and Interdipartimental Research Center for Autoimmune Diseases (IRCAD), 28100 Novara Italy, the §Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm SE-17177, Sweden, and the Division of Clinical Pharmacology, Department of Laboratory Sciences, Karolinska Institutet, Karolinska University Hospital, Huddinge SE-14186, Sweden

The identification of the epitopes recognized by autoantibodies against cytochrome P450s (CYPs) associated with drug-induced hepatotoxicity is difficult because of their conformational nature. In the present investigation, we used a novel approach based on the analysis of the whole molecule antigenic capacity following single amino acid substitutions to identify the conformational epitopes on CYP2E1. A molecular model of CYP2E1 was generated based on the CYP2C5 crystal structure, and potential motifs for amino acid exchanges were selected by computer simulation in the surface of {alpha} helices and {beta} sheets. Fourteen modified, apparently correctly folded CYP2E1 variants were produced in Escherichia coli and evaluated in immunoprecipitation experiments using sera with anti-CYP2E1 autoreactivity from 10 patients with halothane hepatitis and 12 patients with alcoholic liver disease. Ala substitution of Glu-248 and Lys-251 as well as of Lys-324, Lys-342, Lys-420, and Phe-421 severely decreased or abolished CYP2E1 recognition by the majority of both the halothane hepatitis and alcoholic liver disease sera, whereas the other substitutions had only minor effects. Based on the structural model, these substitutions identified two distinct epitopes on the CYP2E1 surface corresponding to the G-helix and an area formed by juxtaposition of the J' and K'' helices, respectively. The combined use of molecular modeling and single amino acid mutagenesis is thus a useful approach for the characterization of conformational epitopes recognized by autoantibodies.


Received for publication, June 30, 2004 , and in revised form, September 3, 2004.

* This work was supported by grants from the Regional Government of Piedmont, the Cariplo Foundation (Milan, Italy), and the Swedish Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Medical Science, University "Amedeo Avogadro" of East Piedmont, Via Solaroli 17, 28100 Novara, Italy. Tel.: 39-0321-660642; Fax: 39-0321-620421; E-mail: albano{at}med.unipmn.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement